Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective Cox-2 inhibitor

Bhupesh Parashar, Sai Latha Shankar, Kathleen O'Guin, James Butler, Bhadrasain Vikram, Bridget Shafit-Zagardo

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Neuroblastomas constitute about 10% of childhood cancers and are responsible for 15% of pediatric cancer mortality. We evaluated the efficacy and the mechanism of cell death induced by CAY10404, a selective cyclooxygenase-2 (Cox-2) inhibitor in four human neuroblastoma cell lines (SH-EP, SH-SY5Y, SK-N-MC and MSN). Treatment with CAY10404 in the range of 15-115 μM revealed a dose-dependent decrease in cell number and an average IC50(inhibitory concentration 50%) of 60 μM. About 20-30% of the cells were terminal deoxynucleotidyltransferase-mediated UTP nick-end-labeling (TUNEL) positive 48 h after treatment. Western blot analysis of CAY10404-treated cells showed poly(ADP-ribose) polymerase (PARP) cleavage and cleaved caspase-3 signifying caspase activity and apoptotic cell death. Inhibitor-of-apoptosis proteins including X-linked inhibitor-of-apoptosis protein (XIAP) and survivin did not change significantly after CAY10404 treatment. Fluorescence activated cell sorter (FACS) analysis performed in two different cell lines 48 h following CAY10404 treatment showed a reduction in the number of cells in the G1 phase of the cell cycle and an increase in the number of cells in the G2 phase. When radioresistant SH-EP cells were treated with CAY10404, a 49% decrease in cell viability was observed relative to DMSO-treated cells; pretreatment with CAY10404 followed by ortho-voltage irradiation further enhanced cell death (58%) suggesting radiosensitization by CAY10404.

Original languageEnglish (US)
Pages (from-to)141-148
Number of pages8
JournalJournal of Neuro-Oncology
Volume71
Issue number2
DOIs
StatePublished - Jan 2005

Fingerprint

Cyclooxygenase 2 Inhibitors
Neuroblastoma
Growth
Cell Death
Cell Count
X-Linked Inhibitor of Apoptosis Protein
Inhibitor of Apoptosis Proteins
Cell Line
Uridine Triphosphate
DNA Nucleotidylexotransferase
Poly(ADP-ribose) Polymerases
G2 Phase
In Situ Nick-End Labeling
G1 Phase
Caspases
Dimethyl Sulfoxide
Caspase 3
Inhibitory Concentration 50
Neoplasms
Cell Survival

Keywords

  • Apoptosis
  • CAY10404
  • Cox-2
  • Neuroblastomas
  • Prostaglandins
  • Radiation
  • Survivin

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective Cox-2 inhibitor. / Parashar, Bhupesh; Shankar, Sai Latha; O'Guin, Kathleen; Butler, James; Vikram, Bhadrasain; Shafit-Zagardo, Bridget.

In: Journal of Neuro-Oncology, Vol. 71, No. 2, 01.2005, p. 141-148.

Research output: Contribution to journalArticle

Parashar, Bhupesh ; Shankar, Sai Latha ; O'Guin, Kathleen ; Butler, James ; Vikram, Bhadrasain ; Shafit-Zagardo, Bridget. / Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective Cox-2 inhibitor. In: Journal of Neuro-Oncology. 2005 ; Vol. 71, No. 2. pp. 141-148.
@article{d67c48c8f9644fada67fda0cbb0d52e3,
title = "Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective Cox-2 inhibitor",
abstract = "Neuroblastomas constitute about 10{\%} of childhood cancers and are responsible for 15{\%} of pediatric cancer mortality. We evaluated the efficacy and the mechanism of cell death induced by CAY10404, a selective cyclooxygenase-2 (Cox-2) inhibitor in four human neuroblastoma cell lines (SH-EP, SH-SY5Y, SK-N-MC and MSN). Treatment with CAY10404 in the range of 15-115 μM revealed a dose-dependent decrease in cell number and an average IC50(inhibitory concentration 50{\%}) of 60 μM. About 20-30{\%} of the cells were terminal deoxynucleotidyltransferase-mediated UTP nick-end-labeling (TUNEL) positive 48 h after treatment. Western blot analysis of CAY10404-treated cells showed poly(ADP-ribose) polymerase (PARP) cleavage and cleaved caspase-3 signifying caspase activity and apoptotic cell death. Inhibitor-of-apoptosis proteins including X-linked inhibitor-of-apoptosis protein (XIAP) and survivin did not change significantly after CAY10404 treatment. Fluorescence activated cell sorter (FACS) analysis performed in two different cell lines 48 h following CAY10404 treatment showed a reduction in the number of cells in the G1 phase of the cell cycle and an increase in the number of cells in the G2 phase. When radioresistant SH-EP cells were treated with CAY10404, a 49{\%} decrease in cell viability was observed relative to DMSO-treated cells; pretreatment with CAY10404 followed by ortho-voltage irradiation further enhanced cell death (58{\%}) suggesting radiosensitization by CAY10404.",
keywords = "Apoptosis, CAY10404, Cox-2, Neuroblastomas, Prostaglandins, Radiation, Survivin",
author = "Bhupesh Parashar and Shankar, {Sai Latha} and Kathleen O'Guin and James Butler and Bhadrasain Vikram and Bridget Shafit-Zagardo",
year = "2005",
month = "1",
doi = "10.1007/s11060-004-1721-3",
language = "English (US)",
volume = "71",
pages = "141--148",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Inhibition of human neuroblastoma cell growth by CAY10404, a highly selective Cox-2 inhibitor

AU - Parashar, Bhupesh

AU - Shankar, Sai Latha

AU - O'Guin, Kathleen

AU - Butler, James

AU - Vikram, Bhadrasain

AU - Shafit-Zagardo, Bridget

PY - 2005/1

Y1 - 2005/1

N2 - Neuroblastomas constitute about 10% of childhood cancers and are responsible for 15% of pediatric cancer mortality. We evaluated the efficacy and the mechanism of cell death induced by CAY10404, a selective cyclooxygenase-2 (Cox-2) inhibitor in four human neuroblastoma cell lines (SH-EP, SH-SY5Y, SK-N-MC and MSN). Treatment with CAY10404 in the range of 15-115 μM revealed a dose-dependent decrease in cell number and an average IC50(inhibitory concentration 50%) of 60 μM. About 20-30% of the cells were terminal deoxynucleotidyltransferase-mediated UTP nick-end-labeling (TUNEL) positive 48 h after treatment. Western blot analysis of CAY10404-treated cells showed poly(ADP-ribose) polymerase (PARP) cleavage and cleaved caspase-3 signifying caspase activity and apoptotic cell death. Inhibitor-of-apoptosis proteins including X-linked inhibitor-of-apoptosis protein (XIAP) and survivin did not change significantly after CAY10404 treatment. Fluorescence activated cell sorter (FACS) analysis performed in two different cell lines 48 h following CAY10404 treatment showed a reduction in the number of cells in the G1 phase of the cell cycle and an increase in the number of cells in the G2 phase. When radioresistant SH-EP cells were treated with CAY10404, a 49% decrease in cell viability was observed relative to DMSO-treated cells; pretreatment with CAY10404 followed by ortho-voltage irradiation further enhanced cell death (58%) suggesting radiosensitization by CAY10404.

AB - Neuroblastomas constitute about 10% of childhood cancers and are responsible for 15% of pediatric cancer mortality. We evaluated the efficacy and the mechanism of cell death induced by CAY10404, a selective cyclooxygenase-2 (Cox-2) inhibitor in four human neuroblastoma cell lines (SH-EP, SH-SY5Y, SK-N-MC and MSN). Treatment with CAY10404 in the range of 15-115 μM revealed a dose-dependent decrease in cell number and an average IC50(inhibitory concentration 50%) of 60 μM. About 20-30% of the cells were terminal deoxynucleotidyltransferase-mediated UTP nick-end-labeling (TUNEL) positive 48 h after treatment. Western blot analysis of CAY10404-treated cells showed poly(ADP-ribose) polymerase (PARP) cleavage and cleaved caspase-3 signifying caspase activity and apoptotic cell death. Inhibitor-of-apoptosis proteins including X-linked inhibitor-of-apoptosis protein (XIAP) and survivin did not change significantly after CAY10404 treatment. Fluorescence activated cell sorter (FACS) analysis performed in two different cell lines 48 h following CAY10404 treatment showed a reduction in the number of cells in the G1 phase of the cell cycle and an increase in the number of cells in the G2 phase. When radioresistant SH-EP cells were treated with CAY10404, a 49% decrease in cell viability was observed relative to DMSO-treated cells; pretreatment with CAY10404 followed by ortho-voltage irradiation further enhanced cell death (58%) suggesting radiosensitization by CAY10404.

KW - Apoptosis

KW - CAY10404

KW - Cox-2

KW - Neuroblastomas

KW - Prostaglandins

KW - Radiation

KW - Survivin

UR - http://www.scopus.com/inward/record.url?scp=20444430109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444430109&partnerID=8YFLogxK

U2 - 10.1007/s11060-004-1721-3

DO - 10.1007/s11060-004-1721-3

M3 - Article

C2 - 15690129

AN - SCOPUS:20444430109

VL - 71

SP - 141

EP - 148

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -